Alzamend Neuro (ALZN) Price to Book (2021 - 2026)
Alzamend Neuro's (ALZN) quarterly Price to Book came in at 5.19 in Q2 2026, up 668.91% year-over-year from 0.67 in Q2 2025, and up 39.54% quarter-over-quarter from 3.72 in Q1 2026.
Analysis
Alzamend Neuro (ALZN) Price to Book (2021 - 2026) Analysis & Trends
Alzamend Neuro has disclosed Price to Book across 6 years of filings, most recently posting 5.19 for Q2 2026.
- In Q2 2026, Price to Book rose 668.91% year-over-year to 5.19; the TTM figure through Apr 2026 stood at 5.19 (up 668.91% YoY), while the FY2026 annual figure was 5.19, up 668.91% from the prior year.
- Price to Book came in at 5.19 for Q2 2026 at Alzamend Neuro, up from 3.72 in the prior quarter.
- In the past five years, Price to Book ranged from a high of 17.41 in Q2 2023 to a low of 389.03 in Q3 2023.
- Average Price to Book over 5 years is 17.54, with a median of 2.19 recorded in 2025.
- Year-over-year, Price to Book slumped 5224.6% in 2023 and soared 668.91% in 2026.
- Over 5 years, Price to Book stood at 12.72 in 2022, then sank by 136.56% to 4.65 in 2023, then jumped by 131.79% to 1.48 in 2024, then surged by 48.83% to 2.2 in 2025, then soared by 135.97% to 5.19 in 2026.
- Per Business Quant data, the three most recent Price to Book figures were 5.19 in Q2 2026, 3.72 in Q1 2026, and 2.2 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 207.68 Bn | 193.69 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 178.73 Bn | 175.55 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 131.05 Bn | 123.20 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 81.79 Bn | 73.80 Bn | 3.93 Bn |
| 5 | Argenx Se | 60.99 Bn | 55.81 Bn | 1.37 Bn |
| 6 | Moderna | 53.41 Bn | 48.27 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.41 Bn | 30.10 Bn | 992.69 Mn |
| 8 | Biogen | 31.72 Bn | 30.43 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 29.53 Bn | 29.53 Bn | 1.16 Mn |
| 10 | Alzamend Neuro | 5.57 Mn | 5.57 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Apr 30, 2026 | 5.19 |
| Jan 31, 2026 | 3.72 |
| Oct 31, 2025 | 2.20 |
| Jul 31, 2025 | 0.89 |
| Apr 30, 2025 | 0.67 |
| Jan 31, 2025 | 2.17 |
| Oct 31, 2024 | 1.48 |
| Jul 31, 2024 | -2.54 |
| Apr 30, 2024 | -1.89 |
| Jan 31, 2024 | -1.33 |
| Oct 31, 2023 | -4.65 |
| Jul 31, 2023 | -389.03 |
| Apr 30, 2023 | 17.41 |
| Jan 31, 2023 | 10.93 |
| Oct 31, 2022 | 12.72 |
| Jul 31, 2022 | 7.59 |
| Apr 30, 2022 | 7.29 |
| Jan 31, 2022 | 11.52 |
| Oct 31, 2021 | 14.60 |
| Jul 31, 2021 | 25.06 |